Success Metrics

Clinical Success Rate
100.0%

Based on 23 completed trials

Completion Rate
100%(23/23)
Active Trials
3(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
5
13%
Ph phase_1
1
3%
Ph phase_4
1
3%
Ph not_applicable
7
18%
Ph phase_3
1
3%

Phase Distribution

1

Early Stage

5

Mid Stage

2

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
5(33.3%)
Phase 3Large-scale testing
1(6.7%)
Phase 4Post-market surveillance
1(6.7%)
N/ANon-phased studies
7(46.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

23 of 23 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

38

all time

Status Distribution
Active(6)
Completed(23)
Other(9)

Detailed Status

Completed23
unknown9
Not yet recruiting3
Recruiting2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (6.7%)
Phase 25 (33.3%)
Phase 31 (6.7%)
Phase 41 (6.7%)
N/A7 (46.7%)

Trials by Status

completed2361%
active_not_recruiting13%
recruiting25%
not_yet_recruiting38%
unknown924%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT07569341

Validation of the Classification for Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases

Completed
NCT05349331Phase 2

Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma

Completed
NCT06248528Not Applicable

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

Active Not Recruiting
NCT07030842

Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma

Completed
NCT06988852Phase 2

FOLFOX-HAIC as Conversion Treatment for Initially Unresectable Colorectal Liver Metastasis

Recruiting
NCT06420440Phase 2

Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model

Recruiting
NCT06542926

NON-COlorectal Liver METastases Undergoing Liver Resection

Not Yet Recruiting
NCT03813953Not Applicable

The Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver Resection

Completed
NCT06311916Phase 4

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Not Yet Recruiting
NCT05250843Phase 2

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Unknown
NCT06013657

Surgical Resection for Hepatocellular Carcinoma

Completed
NCT03766555Not Applicable

Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function

Unknown
NCT05597319

ERAS in Liver Surgery

Completed
NCT05540925

Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer

Completed
NCT05458115

Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma

Unknown
NCT05193253

Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less

Completed
NCT05117047

A Long-term Survival Analysis of Different Surgical Method in Early Hepatocellular Carcinoma

Completed
NCT04513457

Chemotherapy for Resectable Colorectal Liver Metastases

Completed
NCT04553458

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

Completed
NCT03630978

Impact of Sarcopenia on Postoperative Outcomes of Patients Undergoing Liver Resection

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
38